Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateHeureSourceTitreSymboleSociété
04/04/202514h39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
31/03/202514h33Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
31/03/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
25/03/202523h29Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
21/03/202522h00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
14/03/202521h30GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price RequirementNASDAQ:TRIBTrinity Biotech PLC
13/03/202512h30GlobeNewswire Inc.Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment ProcessNASDAQ:TRIBTrinity Biotech PLC
28/02/202514h30GlobeNewswire Inc.Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring TechnologyNASDAQ:TRIBTrinity Biotech PLC
06/02/202513h30GlobeNewswire Inc.Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialNASDAQ:TRIBTrinity Biotech PLC
28/01/202513h20GlobeNewswire Inc.Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyNASDAQ:TRIBTrinity Biotech PLC
27/12/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
27/12/202400h19Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:TRIBTrinity Biotech PLC
24/12/202414h33GlobeNewswire Inc.Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanNASDAQ:TRIBTrinity Biotech PLC
18/12/202417h00GlobeNewswire Inc.Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVNASDAQ:TRIBTrinity Biotech PLC
29/11/202422h45Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:TRIBTrinity Biotech PLC
15/11/202415h00GlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
14/11/202423h26Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
07/11/202414h19GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
25/10/202414h45GlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
25/10/202414h45GlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
07/10/202414h15GlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
24/09/202422h05GlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
18/09/202422h05GlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
09/09/202422h05GlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
03/09/202415h55GlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
26/08/202422h05GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesNASDAQ:TRIBTrinity Biotech PLC
20/08/202423h00GlobeNewswire Inc.Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing DirectorNASDAQ:TRIBTrinity Biotech PLC
14/08/202413h30GlobeNewswire Inc.Trinity Biotech Announces Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
13/08/202422h05GlobeNewswire Inc.Trinity Biotech to Announce Q2 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
06/08/202422h05GlobeNewswire Inc.Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Dernières Valeurs Consultées

Delayed Upgrade Clock